Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ghiaseddin, A; Reardon, DA; Massey, W; Mannerino, A; Lipp, ES; Herndon, JE; McSherry, F; Desjardins, A; Randazzo, DM; Vlahovic, G; Friedman, HS; Peters, KB

Published Date

  • May 20, 2015

Published In

Volume / Issue

  • 33 / 15_suppl

Start / End Page

  • 2034 - 2034

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2015.33.15_suppl.2034